Negatively Impacted By COVID-19, The Gastric Cancer Drugs Market Size Is To Recover Over The Next Few Years

GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe. On July 06, 2021, it released an article on the gastric cancer drugs market, sourced from TBRC's Global Gastric Cancer Drugs Market report. Global Gastric Cancer Drugs Market by TBRC is segmented as Doxorubicin Hydrochloride, Sunitinib, Docetaxel, Mitomycin, Fluorouracil, Imatinib